Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ID1201 in mild Alzheimer's disease
NCT03363269Phase 2Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Apr 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ID1201 in Alzheimer's disease (AD), sponsored by Ildong Pharmaceutical Co Ltd. Started Apr 2016; status: completed.
02
Drugs
ID1201
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03363269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03363269.